| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 255 | 81.600 | 20141112, Nieto M
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 11.900 | 20140625, Armentia A
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 2.000 | 20140625, Armentia A
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 4.000 | 20140625, Armentia A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 16.000 | 20140821, Choi JS
| | 1.4 - Respiratory Symptoms, Diagnosed | 2013 | Spain | IgE | 187 | 19.800 | 20131016, Feliu A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 15.710 | 20130111, Ott H
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 9.200 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 11.430 | 20130605, Simon D
| | 6.2 - General Population (Adults) | 2012 | Sweden | BPT | 371 | 1.080 | 20120528, Patelis A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 17.170 | 20110223, De Knop KJ
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 6.250 | 20120528, Patelis A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Austria | IgE | 54 | 98.150 | 20120310, Twaroch TE
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 42 | 97.600 | 20120529, Morin M
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Italy | IgE | 26 | 96.150 | 20120310, Twaroch TE
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 9.560 | 20100301, Scala E
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 24.410 | 20101214, Gadisseur R
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Spain | IgE | 21 | 95.230 | 20101125, Fernandez C
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 8.100 | 20090826, Ebo DG
| | 10.1 - Normal Control | 2009 | Belgium | BPT | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | BPT | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 20.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 90.000 | 20091005, Ott H
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2005 | Spain | IgE | 42 | 97.600 | 20050610, Asturias JA
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2003 | United States | IgE | 57 | 80.700 | 2003, Kurup VP
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2001 | United States | IgE | 58 | 75.900 | 2001a, Vailes LD
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2001 | United States | IgE | 19 | 52.600 | 2001a, Vailes LD
| | 3.2.1 - Source Sensitized (IgE) | 1996 | Canada | IgE (IB) | 57 | 80.700 | 1996, De Vouge MW
|
|
Loading...
Alt a 1
Homo sapiens
